Fifth Third Bancorp
- SEC CIK
- 0000035527
- Latest filing
- Aug 5, 2026
SYRS holding history
Syros Pharmaceuticals, Inc. in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYRS overviewAll 13F holders of SYRSFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −129−100.0% | Sold out | Holders |
| Q3 2024 | 129 | $277 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 129 | $666 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 129 | $690 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 129 | $1.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 129 | $510 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 129 | $406 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 129 | $344 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 129 | $463 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 129 | $1.00K | <0.1% | +129 | New | Holders |